Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marine Gilabert

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Journal of Hepatocellular Carcinoma|November 23, 2018
Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoproteinMarine Gilabert, Jean-Luc Raoul
Bulletin Du Cancer|April 3, 2014
[Exemestane-everolimus in HER2-negative, hormonal receptor-positive, post-menopausal metastatic breast cancer with resistance to non-steroidal aromatase inhibitor: a new option]Marine Gilabert, Simon Launay, Anthony Gonçalves
Liver Cancer|June 20, 2014
How to define transarterial chemoembolization failure or refractoriness: a European perspectiveJean-Luc Raoul, Marine Gilabert, Gilles Piana
Oncology|November 14, 2016
Targeted Therapies Provide Treatment Options for Poorly Differentiated Pancreatic Neuroendocrine CarcinomasMarine Gilabert, Young Soo Rho, Petr Kavan
Journal of Geriatric Oncology|September 11, 2017
How to treat pancreatic adenocarcinoma in elderly: How far can we go in 2017?Marine Gilabert, Jean Luc Raoul, Frederique Rousseau
World Journal of Hepatology|January 5, 2017
How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinomaJean-Luc Raoul, Xavier Adhoute, Marine Gilabert, et al.
Nature Reviews. Clinical Oncology|August 6, 2014
Treatment of intermediate-stage hepatocellular carcinomaAlejandro Forner, Marine Gilabert, Jordi Bruix, et al.
Expert Opinion on Pharmacotherapy|September 13, 2017
An in-depth review of chemical angiogenesis inhibitors for treating hepatocellular carcinomaJean-Luc Raoul, Marine Gilabert, Xavier Adhoute, et al.
La Revue Du Praticien|March 22, 2013
[Palliative treatment for hepatocellular carcinoma]Jean-Luc Raoul, Marine Gilabert, Sandrine Oziel-Taïeb, et al.
Hepatic Oncology|June 28, 2019
Current options and future possibilities for the systemic treatment of hepatocellular carcinomaJean-Luc Raoul, Jean-Sébastien Frenel, Judith Raimbourg, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Journal of Hepatocellular Carcinoma|November 23, 2018
Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoproteinMarine Gilabert, Jean-Luc Raoul
Bulletin Du Cancer|April 3, 2014
[Exemestane-everolimus in HER2-negative, hormonal receptor-positive, post-menopausal metastatic breast cancer with resistance to non-steroidal aromatase inhibitor: a new option]Marine Gilabert, Simon Launay, Anthony Gonçalves
Liver Cancer|June 20, 2014
How to define transarterial chemoembolization failure or refractoriness: a European perspectiveJean-Luc Raoul, Marine Gilabert, Gilles Piana
Oncology|November 14, 2016
Targeted Therapies Provide Treatment Options for Poorly Differentiated Pancreatic Neuroendocrine CarcinomasMarine Gilabert, Young Soo Rho, Petr Kavan
Journal of Geriatric Oncology|September 11, 2017
How to treat pancreatic adenocarcinoma in elderly: How far can we go in 2017?Marine Gilabert, Jean Luc Raoul, Frederique Rousseau
World Journal of Hepatology|January 5, 2017
How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinomaJean-Luc Raoul, Xavier Adhoute, Marine Gilabert, et al.
Nature Reviews. Clinical Oncology|August 6, 2014
Treatment of intermediate-stage hepatocellular carcinomaAlejandro Forner, Marine Gilabert, Jordi Bruix, et al.
Expert Opinion on Pharmacotherapy|September 13, 2017
An in-depth review of chemical angiogenesis inhibitors for treating hepatocellular carcinomaJean-Luc Raoul, Marine Gilabert, Xavier Adhoute, et al.
La Revue Du Praticien|March 22, 2013
[Palliative treatment for hepatocellular carcinoma]Jean-Luc Raoul, Marine Gilabert, Sandrine Oziel-Taïeb, et al.
Hepatic Oncology|June 28, 2019
Current options and future possibilities for the systemic treatment of hepatocellular carcinomaJean-Luc Raoul, Jean-Sébastien Frenel, Judith Raimbourg, et al.
Pageof 7